emocha Mobile Health
eMocha is an online platform for video Directly Observed Therapy.
eMocha is a video Directly Observed Therapy tool.
It is a HIPAA-compliant mobile app that lets patients record a video of themselves taking their meds and send it to their care provider. It aims to help people comply with their medication regimens and reduce the risks that are associated with failing to take the prescribed medication.
Using the apps, patients report side effects or symptoms and record every dose of medication using the emocha smartphone app. Care providers are also able to communicate with patients and review their progress from the eMocha web platform.
Implementing organizations and partners:
- Maryland Innovation Initiative
- BioHealth Innovation
- Kapor Capital
- NIH – National Institute of Drug Abuse
- NIH – National Institute on Minority Health and Health Disparities
- SBIR – STTR
The app can be downloaded for free from Google Play.
Goal 3: Good health and well-being
Target users include public health departments, clinical trials, health systems, and managed care organizations.
Users can download the app for free in Google Play.
10,000+ app installs according to Google Play as of 2020.
Connectivity requirement for the product/service to work (mobile internet, SMS, voice, fixed internet, Wi-Fi, other [specify]).
Coverage required for the product/service to work (2G, 3G, 4G, LTE, broadband, dial-up, other [specify]).
Device features required for the product/service to work (bluetooth, Wi-Fi, camera, IVR, GPS, accelerometers/motion sensors, physiologic biosensors, biometric identifiers, SIM, memory card (e.g microSD), other [specify]).
Device(s) type required for the product/service to work (smartphone, feature phone, computer, tablet, other [specify]).
Connectivity requirement for the product/service to work. Some apps/services can work offline. If no, specify if network connectivity is needed at any point (e.g connectivity needed for download).
Is the product/service able to receive and send back information to the user?
Rates of user vs downloads/subscriptions – Compliance rate for the eHealth service
Support according to the literacy level required from the user. If yes, specify type of literacy support. If no, the user is intended to be literate.
Operating system required and software version (Android, IOs, Windows, other [specify])
Power supply required for the product/service to work (uninterrupted prower supply (UPS), ocassional power supply [minimum time required], other).
Education and behavior change, human resource management, decision support, data collection & analytics, electronic medical records, Healthcare provider- CHW training, telemedicine/remote diagnostic, stock management, disease surveillance and reporting
eMocha is a smartphone application that allows patients to indicate symptoms and record themselves taking their medication. The patient can then securely submit this information to the eMocha server, where a clinician can then observe and confirm medication adherence using the eMocha web interface. The system also includes a notifications feature to remind patients to take their medication and inform providers about important patient-reported events.
The app can be accessed from the Play Store for users while implementing organization have access to a web interface where they can monitor patient data. The app allows for:
- Dose-by-dose tracking using video Directly Observed Therapy (DOT).
- Patient-doctor communication.
The application of the app is majorly where Directly Observed Therapy is needed in order to enforce adherence to medication regimen.
Provided by the manufacturer.
eMocha seeks to enforce dose by dose adherence, amplify the patient engagement, focus resources, reduce costs, and improve outcomes.
eMocha has been implemented in Harris County (TX) and Baltimore (MD). Data is actively being gathered on usability, patient adherence, and cost savings at four Maryland health departments with support from an NIH grant. miDOT is also being used in an adherence-related study of Hepatitis C Virus in Denver, CO. miDOT will soon be tested in Pune and Bangalore, India.
In a National Institute of Minority Health and Health Disparities Small Business Innovation Research grant across 3 Maryland public health departments, 100% of patients successfully completed tuberculosis treatment.
Public health departments and academic medical centers have evaluated emocha with support from the National Institute on Minority Health and Health Disparities, the National Institute on Drug Abuse, and the Patient Centered Outcomes Research Institute.
No known safety hazards are related to this product.
Hatef, E., Sharfstein, J., Labrique, A., 2018, Innovation and Entrepreneurship: Harnessing the Public Health Skill Set in a New Era of Health Reforms and Investment. Journal of Public Health Management and Practice, 2, 99-101.
Bollinger, R., et al., 2011, Building a Global Health Education Network for Clinical Care and Research. The Benefits and Challenges of Distance Learning Tools. Lessons Learned from the Hopkins Center for Clinical Global Health Education. Infectious Disease Clinics , Volume 25 , Issue 2 , 385 – 398.
Veronica N., Kalengé, S., Kelley, J., Wilson, A., Muliira, J., Nabirye, R., Glass, N., Bollinger, R., Stella, A., Chang, L., 2021, Research Capacity–Building Program for Clinicians and Staff at a Community-Based HIV Clinic in Uganda: A Pre/Post Evaluation. Journal of the Association of Nurses in AIDS Care, Volume 23, Issue 5, 2012, Pages 431-441, ISSN 1055-3290
Hoffman, J. A., Cunningham, J.R., Suleh, A.J., Sundsmo, A., Dekker, D., Vago, F., Munly, K., Igonya, E. K., Hunt-Glassman, J., 2010, Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med. 2010 Jul; 39(1):78-80.
Solution tested by partner organizations:
- Pathway Healthcare case studies for opioid use disorder
- Harris County, Texas has used emocha for active and latent TB treatment with over 400 patients since 2014
- Massachusetts General Hospital case studies for HCV treatment
- Baltimore City, Philadelphia, and Washington, D.C. case studies for HIV and PrEP treatments
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.